The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Johnston David Brannon since 2011.
The trader's CIK number is 1486519.
At the time of the last reporting, Johnston David Brannon was the Chief Financial Officer of Immunogen, Inc.. (stock ticker symbol IMGN).
Also see all insider trading activities at Immunogen, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | AVEO | 0 | $0 | 2,211 | $16,720 | 0 | $0 |
| 2012 | AVEO | 0 | $0 | 17,493 | $212,641 | 15,000 | $84,000 |
| 2011 | AVEO | 0 | $0 | 8,906 | $143,546 | 7,000 | $39,200 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | IMGN | 0 | $0 | 41,060 | $454,422 | 20,000 | $61,000 |
| 2016 | IMGN | 10,000 | $16,980 | 0 | $0 | 0 | $0 |
| 2015 | IMGN | 0 | $0 | 10,000 | $160,180 | 10,000 | $107,898 |
1. Aveo Pharmaceuticals, Inc. (AVEO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-03-14 | AVEO | Sale | 1,061 | 7.34 | 7,784 |
| 2013-01-28 | AVEO | Sale | 1,150 | 7.77 | 8,936 |
| 2012-09-13 | AVEO | Sale | 1,386 | 10.60 | 14,695 |
| 2012-06-06 | AVEO | Option Ex | 15,000 | 5.60 | 84,000 |
| 2012-06-06 | AVEO | Sale | 15,000 | 12.21 | 183,150 |
| 2012-01-26 | AVEO | Sale | 1,107 | 13.37 | 14,796 |
| 2011-12-01 | AVEO | Option Ex | 1,000 | 5.60 | 5,600 |
| 2011-12-01 | AVEO | Sale | 1,000 | 16.74 | 16,737 |
| 2011-11-01 | AVEO | Option Ex | 2,000 | 5.60 | 11,200 |
| 2011-11-01 | AVEO | Sale | 2,000 | 15.44 | 30,878 |
| 2011-10-03 | AVEO | Option Ex | 2,000 | 5.60 | 11,200 |
| 2011-10-03 | AVEO | Sale | 2,000 | 15.43 | 30,868 |
| 2011-09-01 | AVEO | Option Ex | 2,000 | 5.60 | 11,200 |
| 2011-09-01 | AVEO | Sale | 2,000 | 16.87 | 33,748 |
| 2011-08-24 | AVEO | Sale | 1,906 | 16.43 | 31,315 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-06-06 | IMGN | Option Ex | 10,000 | 3.05 | 30,500 |
| 2018-06-06 | IMGN | Sale | 10,000 | 11.02 | 110,200 |
| 2018-03-15 | IMGN | Option Ex | 10,000 | 3.05 | 30,500 |
| 2018-03-15 | IMGN | Sale | 10,000 | 11.53 | 115,300 |
| 2018-02-21 | IMGN | Sale | 21,060 | 10.87 | 228,922 |
| 2016-11-02 | IMGN | Buy | 10,000 | 1.70 | 16,980 |
| 2015-09-17 | IMGN | Sale | 5,000 | 15.00 | 75,000 |
| 2015-09-17 | IMGN | Option Ex | 5,000 | 10.79 | 53,949 |
| 2015-08-03 | IMGN | Option Ex | 5,000 | 10.79 | 53,949 |
| 2015-08-03 | IMGN | Sale | 5,000 | 17.04 | 85,180 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Johnston David Brannon (Chief Financial Officer of Immunogen, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.